High-sensitivity C-reactive protein and bilirubin as possible biomarkers for hikikomori in depression: A case-control study

Sota Kyuragi; Toshio Matsushima; Keitaro Matsuo; Tomohiro Nakao; Takahiro A. Kato

doi:10.1111/pcn.13564

High-sensitivity C-reactive protein and bilirubin as possible biomarkers for hikikomori in depression: A case-control study

Sota Kyuragi, Toshio Matsushima, Keitaro Matsuo, Tomohiro Nakao, Takahiro A. Kato

研究成果: ジャーナルへの寄稿 › レター › 査読

本文言語	英語
ページ（範囲）	458-460
ページ数	3
ジャーナル	Psychiatry and clinical neurosciences
巻	77
号	8
DOI	https://doi.org/10.1111/pcn.13564
出版ステータス	出版済み - 8月 2023

!!!All Science Journal Classification (ASJC) codes

神経科学一般
神経学
臨床神経学
精神医学および精神衛生

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1111/pcn.13564

他のファイルとリンク

引用スタイル

@article{329e8082fdcf4d6cab16d32d00295cdc,

title = "High-sensitivity C-reactive protein and bilirubin as possible biomarkers for hikikomori in depression: A case-control study",

author = "Sota Kyuragi and Toshio Matsushima and Keitaro Matsuo and Tomohiro Nakao and Kato, {Takahiro A.}",

note = "Funding Information: This work was partially supported by a Grant‐in‐Aid for Scientific Research: (1) The Japan Society for the Promotion of Science (KAKENHI; JP18H04042, JP19K21591, JP20H01773, and JP22H00494 to TAK), (2) The Japan Agency for Medical Research and Development (AMED; JP21wm0425010 to TAK) and (3) The Japan Science and Technology Agency CREST (JPMJCR22N5 to TAK). The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. ",

year = "2023",

month = aug,

doi = "10.1111/pcn.13564",

language = "English",

volume = "77",

pages = "458--460",

journal = "Psychiatry and clinical neurosciences",

issn = "1323-1316",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

TY - JOUR

T1 - High-sensitivity C-reactive protein and bilirubin as possible biomarkers for hikikomori in depression

T2 - A case-control study

AU - Kyuragi, Sota

AU - Matsushima, Toshio

AU - Matsuo, Keitaro

AU - Nakao, Tomohiro

AU - Kato, Takahiro A.

N1 - Funding Information: This work was partially supported by a Grant‐in‐Aid for Scientific Research: (1) The Japan Society for the Promotion of Science (KAKENHI; JP18H04042, JP19K21591, JP20H01773, and JP22H00494 to TAK), (2) The Japan Agency for Medical Research and Development (AMED; JP21wm0425010 to TAK) and (3) The Japan Science and Technology Agency CREST (JPMJCR22N5 to TAK). The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.

PY - 2023/8

Y1 - 2023/8

UR - http://www.scopus.com/inward/record.url?scp=85160274725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85160274725&partnerID=8YFLogxK

U2 - 10.1111/pcn.13564

DO - 10.1111/pcn.13564

M3 - Letter

C2 - 37166682

AN - SCOPUS:85160274725

SN - 1323-1316

VL - 77

SP - 458

EP - 460

JO - Psychiatry and clinical neurosciences

JF - Psychiatry and clinical neurosciences

IS - 8

ER -